Matinas BioPharma Holdings Inc (MTNB) — Long-term Investment Intensity

Latest as of September 2016: 0.5%

Matinas BioPharma Holdings Inc (MTNB) has a Long-term Investment Intensity of 0.5% as of September 2016. Long-term investments of $54.84K represent 0.5% of total assets of $11.31 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check how resilient are Matinas BioPharma Holdings Inc's assets to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

0.5%
LT Investments / Total Assets

Long-term Investments

$54.84K
USD

Total Assets

$11.31 Million
USD

Country

USA
NYSE MKT

Matinas BioPharma Holdings Inc Long-term Investment Intensity (2014–2015)

This chart shows how Matinas BioPharma Holdings Inc's Long-term Investment Intensity has evolved across 2 annual periods from 2014 to 2015. As of September 2016, the intensity stands at 0.5%, reflecting long-term investments of $54.84K against total assets of $11.31 Million USD. For the complete balance sheet picture, see balance sheet size of Matinas BioPharma Holdings Inc.

Annual Long-term Investment Intensity for Matinas BioPharma Holdings Inc (2014–2015)

The table below presents the year-by-year Long-term Investment Intensity for Matinas BioPharma Holdings Inc from 2014 to 2015, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Matinas BioPharma Holdings Inc for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2015 1.4% $115.37K $8.41 Million ▼ -5.1 pp
2014 6.4% $216.32K $3.36 Million
pp = percentage points